These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30465453)

  • 1. Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics.
    Howard M; Barber J; Alizai N; Rostami-Hodjegan A
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1315-1330. PubMed ID: 30465453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.
    Hartmanshenn C; Scherholz M; Androulakis IP
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):481-504. PubMed ID: 27647273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine.
    Marsousi N; Desmeules JA; Rudaz S; Daali Y
    J Pharm Sci; 2017 Sep; 106(9):2380-2391. PubMed ID: 28456730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Promises of Quantitative Proteomics in Precision Medicine.
    Prasad B; Vrana M; Mehrotra A; Johnson K; Bhatt DK
    J Pharm Sci; 2017 Mar; 106(3):738-744. PubMed ID: 27939376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.
    Ke AB; Greupink R; Abduljalil K
    CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):103-110. PubMed ID: 29349870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populations.
    Sychterz C; Galetin A; Taskar KS
    Biopharm Drug Dispos; 2021 Apr; 42(4):160-177. PubMed ID: 33759451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-Informed Dose Optimization in Pregnancy.
    Chaphekar N; Caritis S; Venkataramanan R
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S63-S76. PubMed ID: 33205432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometrics in pregnancy: An unmet need.
    Ke AB; Rostami-Hodjegan A; Zhao P; Unadkat JD
    Annu Rev Pharmacol Toxicol; 2014; 54():53-69. PubMed ID: 24392692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Dose Selection and Utility of PBPK in Determining Dose.
    Templeton IE; Jones NS; Musib L
    AAPS J; 2018 Feb; 20(2):31. PubMed ID: 29441439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.
    Galetin A; Zhao P; Huang SM
    J Pharm Sci; 2017 Sep; 106(9):2204-2208. PubMed ID: 28390843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
    Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.
    Yee KL; Li M; Cabalu T; Sahasrabudhe V; Lin J; Zhao P; Jadhav P
    J Clin Pharmacol; 2018 Mar; 58(3):364-376. PubMed ID: 29077203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
    Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
    Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine.
    Paliwal A; Jain S; Kumar S; Wal P; Khandai M; Khandige PS; Sadananda V; Anwer MK; Gulati M; Behl T; Srivastava S
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):181-195. PubMed ID: 38480460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
    Verscheijden LFM; Koenderink JB; Johnson TN; de Wildt SN; Russel FGM
    Pharmacol Ther; 2020 Jul; 211():107541. PubMed ID: 32246949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
    Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
    Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.